▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extr 8.4375
E 12.015625
me 8.7109375
▁issue 10.703125
▁among 8.1796875
▁at 7.1796875
▁least 1.720703125
▁ 2.87890625
8 3.302734375
% 5.3125
▁of 0.9873046875
▁the 0.9697265625
▁residents 6.40625
▁of 2.744140625
▁progress 10.703125
ive 1.4296875
▁countries 7.56640625
. 2.06640625
▁The 2.5
▁introduction 8.265625
▁of 0.2200927734375
▁the 1.7802734375
▁study 6.82421875
▁describes 8.09375
▁the 0.7314453125
▁apparent 8.96875
▁link 6.640625
▁between 0.55322265625
▁pain 6.51171875
▁and 0.88818359375
▁dem 8.4296875
oral 3.28515625
ization 0.30859375
. 1.59375
▁Chron 6.02734375
ic 0.0223236083984375
▁pain 0.302001953125
▁is 1.3388671875
▁Always 13.9296875
▁accompanied 4.94921875
▁by 0.08624267578125
▁negative 5.06640625
▁emot 1.4619140625
ional 1.384765625
▁experiences 3.099609375
▁and 2.248046875
▁blocks 10.828125
▁a 4.18359375
▁person 1.6123046875
’ 24.203125
s 2.564453125
▁ability 1.736328125
▁to 0.0557861328125
▁receive 6.41796875
▁joy 4.8671875
▁and 1.326171875
▁satisfaction 3.07421875
▁from 1.171875
▁life 1.169921875
. 0.34130859375
▁The 1.9658203125
▁research 4.03515625
▁investig 5.26171875
ates 0.443603515625
▁the 0.525390625
▁development 6.28125
▁of 0.20751953125
▁de 4.26171875
pression 0.326904296875
▁and 1.259765625
▁anx 2.62890625
iety 0.006984710693359375
▁among 2.263671875
▁patients 3.1875
▁Rece 7.6953125
iving 0.701171875
▁ph 7.25390625
arma 1.6005859375
ce 0.01318359375
ut 0.00072479248046875
ical 0.0133056640625
▁op 4.7734375
io 0.1746826171875
ids 0.75048828125
▁and 2.548828125
▁medical 6.30859375
▁mar 1.931640625
iju 0.026031494140625
ana 0.0004363059997558594
▁( 4.1171875
MM 1.4609375
) 3.18359375
▁as 2.978515625
▁severe 9.953125
▁p 6.3828125
A 7.7578125
ink 8.2578125
ill 8.03125
ers 0.5810546875
. 0.80615234375
▁It 3.537109375
▁comp 5.28515625
ares 0.0457763671875
▁the 0.67138671875
▁eff 9.5234375
i 2.314453125
C 2.337890625
acy 2.7578125
▁of 0.2142333984375
▁pres 5.85546875
cri 1.71875
ptions 0.9794921875
▁and 2.283203125
▁exam 7.70703125
ines 0.029571533203125
▁the 0.42626953125
▁possibility 4.50390625
▁of 0.1085205078125
▁post 7.1328125
- 1.1982421875
tre 2.451171875
at 0.01522064208984375
ment 0.06988525390625
▁de 2.2265625
pression 0.1031494140625
. 1.794921875
<0x0A> 2.724609375
There 4.91796875
▁is 1.087890625
▁currently 4.37109375
▁a 1.3359375
▁severe 4.9375
▁lack 3.72265625
▁of 0.035064697265625
▁information 2.28125
▁about 1.5478515625
▁the 0.52099609375
▁effects 2.787109375
▁of 0.08294677734375
▁op 1.6123046875
i 4.00390625
ates 0.2406005859375
. 3.95703125
▁They 5.07421875
▁manage 9.5390625
▁pain 3.564453125
▁successfully 5.984375
, 1.3388671875
▁but 0.4072265625
▁the 2.7734375
▁past 9.1796875
▁few 2.59375
▁dec 0.802734375
ades 0.000751495361328125
▁indicated 9.234375
▁the 2.201171875
▁growing 4.6953125
▁concern 3.4765625
▁regarding 2.931640625
▁op 3.076171875
iate 0.9150390625
▁ab 1.5966796875
use 0.008941650390625
▁in 3.435546875
▁forms 10.5546875
▁of 0.467529296875
▁over 3.423828125
d 0.398193359375
ose 0.12493896484375
▁and 0.6982421875
▁add 1.4248046875
iction 0.0304718017578125
. 0.222900390625
▁A 3.986328125
▁more 5.96484375
▁manage 8.875
able 0.0157318115234375
▁and 2.23046875
▁sa 2.619140625
fer 0.0013294219970703125
▁alternative 1.75
▁might 6.37890625
▁be 0.2265625
▁medical 2.779296875
▁mar 0.1761474609375
iju 0.0111846923828125
ana 0.005611419677734375
. 1.56640625
▁However 2.890625
, 0.00974273681640625
▁the 1.69140625
▁legal 4.34765625
▁status 1.169921875
▁and 2.673828125
▁novel 9.5078125
ty 0.7939453125
▁of 0.2235107421875
▁this 1.62109375
▁drug 1.97265625
▁do 5.3046875
▁not 0.088134765625
▁allow 1.158203125
▁finding 9.1953125
▁a 2.271484375
▁large 4.015625
▁number 1.5126953125
▁of 0.00830078125
▁studies 1.26953125
▁on 1.6552734375
▁its 1.0712890625
▁effect 2.25390625
iveness 0.39599609375
. 0.9765625
▁Spe 10.125
ci 3.037109375
F 2.9296875
ically 3.6875
, 0.204345703125
▁it 3.130859375
▁concerns 6.08203125
▁the 0.60986328125
▁emot 7.015625
ional 0.0210113525390625
▁condition 5.61328125
▁of 0.320556640625
▁patients 0.755859375
▁experien 6.76953125
cing 0.003490447998046875
▁chron 1.466796875
ic 0.00568389892578125
▁pain 0.1453857421875
. 0.884765625
▁This 3.201171875
▁research 2.974609375
▁paper 6.57421875
▁a 2.392578125
ims 0.0008244514465332031
▁to 0.11248779296875
▁analyze 3.23828125
▁levels 9.3046875
▁of 0.0419921875
▁de 0.57177734375
pression 0.04388427734375
▁and 0.2430419921875
▁anx 0.05133056640625
iety 0.00582122802734375
▁among 0.82421875
▁people 3.64453125
▁receiving 0.9638671875
▁ther 7.17578125
apy 0.26123046875
▁by 5.12109375
▁comparing 8.140625
▁the 1.02734375
▁effects 1.9228515625
▁of 0.03338623046875
▁ph 2.654296875
arma 0.08489990234375
ce 0.0055389404296875
ut 0.00395965576171875
ical 0.0030517578125
▁op 0.2110595703125
io 0.1435546875
ids 0.06158447265625
▁and 0.324462890625
▁MM 1.994140625
. 0.953125
<0x0A> 1.1064453125
The 1.4443359375
▁study 2.21875
▁was 2.244140625
▁conducted 0.86279296875
▁in 1.5556640625
▁the 1.4375
▁form 2.55078125
▁of 0.0174407958984375
▁collection 9.8828125
▁and 1.7080078125
▁analysis 0.72021484375
▁of 0.048553466796875
▁statistical 4.2890625
▁data 0.12646484375
. 0.951171875
▁Part 4.921875
icip 0.07012939453125
ants 0.06781005859375
▁were 0.76611328125
▁rec 3.138671875
ru 0.003406524658203125
ited 0.0007128715515136719
▁for 4.046875
▁six 7.78515625
▁months 0.5126953125
▁at 3.841796875
▁two 2.564453125
▁major 5.484375
▁pain 4.4453125
▁relief 5.87109375
▁cent 1.4755859375
ers 0.05792236328125
▁in 0.7568359375
▁Israel 4.25
. 0.434814453125
▁The 1.203125
▁research 2.23828125
ers 1.4482421875
▁used 2.724609375
▁The 7.2734375
▁De 4.19140625
pression 0.02191162109375
▁Module 9.9375
▁of 0.953125
▁the 0.374267578125
▁Pat 2.26953125
ient 0.01114654541015625
▁Health 0.119140625
▁Question 0.019989013671875
naire 0.032928466796875
▁and 3.439453125
▁the 0.79296875
▁General 1.7529296875
ized 0.697265625
▁An 0.020263671875
x 0.003047943115234375
iety 0.004535675048828125
▁Dis 0.56640625
order 0.040283203125
▁Sc 1.2177734375
ale 0.09619140625
▁to 1.85546875
▁interview 7.22265625
▁participants 2.03125
, 3.716796875
▁evaluate 5.39453125
▁their 0.74365234375
▁answers 6.6484375
, 0.88427734375
▁and 0.1583251953125
▁conduct 4.5859375
▁the 2.28125
▁study 2.42578125
. 0.234619140625
▁To 5.17578125
▁specifically 10.0859375
▁evaluate 2.41015625
▁and 4.36328125
▁compare 0.94970703125
▁the 0.321533203125
▁prob 10.6796875
abilities 0.5341796875
▁of 0.134521484375
▁de 0.84326171875
press 3.30859375
I 8.796875
on 0.1995849609375
▁or 4.55078125
▁anx 0.07659912109375
iety 0.0242462158203125
▁among 1.779296875
▁the 2.224609375
▁diverse 8.9921875
▁groups 1.5390625
, 1.552734375
▁the 1.046875
▁study 2.85546875
▁used 1.5361328125
▁multiple 4.734375
▁log 2.822265625
istic 0.057342529296875
▁regression 0.1236572265625
▁analysis 0.67919921875
▁and 2.583984375
▁chose 8.8671875
▁medical 7.56640625
▁mar 0.354736328125
iju 0.01343536376953125
ana 0.008056640625
▁as 0.81103515625
▁the 0.96533203125
▁control 2.505859375
▁group 0.58349609375
. 0.294921875
<0x0A> 0.876953125
This 3.3984375
▁type 5.99609375
▁of 0.0124664306640625
▁study 1.8408203125
▁is 1.255859375
▁the 3.35546875
▁most 2.0078125
▁reve 9.1640625
aling 0.0144195556640625
▁and 1.046875
▁inclus 6.48828125
ive 0.0037403106689453125
, 2.345703125
▁as 1.994140625
▁it 0.3603515625
▁contains 4.94921875
▁direct 6.2734375
▁responses 4.921875
▁from 0.80859375
▁a 3.900390625
▁large 0.900390625
▁number 0.467041015625
▁of 0.004817962646484375
▁participants 1.498046875
. 0.6787109375
▁All 4.58203125
▁tools 9.1640625
▁in 4.48046875
▁the 0.7060546875
▁form 3.677734375
▁of 0.044189453125
▁question 1.8291015625
na 0.040802001953125
ires 0.0017528533935546875
▁an 9.1796875
D 2.416015625
▁scales 3.267578125
▁have 3.740234375
▁already 4.5546875
▁been 0.156494140625
▁used 1.962890625
▁and 2.1484375
▁proved 4.171875
▁their 1.4697265625
▁effic 3.6484375
acy 0.0029964447021484375
▁for 3.646484375
▁collect 4.4140625
ing 0.016876220703125
▁analyt 8.421875
ical 0.302490234375
▁data 0.251953125
. 0.471435546875
▁It 3.560546875
▁helps 4.82421875
▁to 0.89697265625
▁system 7.23828125
at 1.0068359375
ize 0.0216064453125
▁and 1.5947265625
▁class 3.927734375
ify 0.006595611572265625
▁distinct 9.4140625
▁kinds 6.12109375
▁of 0.0272674560546875
▁information 3.447265625
▁for 3.8984375
▁subsequent 3.9609375
▁un 8.0390625
comp 6.09375
licated 0.0709228515625
▁services 11.8046875
. 0.64306640625
▁Thus 4.4140625
, 0.03466796875
▁research 4.6015625
ers 0.59619140625
▁can 1.40625
▁compare 3.869140625
▁the 0.96484375
▁effects 3.0546875
▁of 0.10931396484375
▁medic 4.3203125
ations 0.99951171875
▁on 1.689453125
▁patients 2.060546875
▁of 4.296875
▁diverse 4.0390625
▁age 2.869140625
▁groups 0.61328125
, 0.90283203125
▁background 5.11328125
s 0.230224609375
, 0.07586669921875
▁physical 5.484375
▁conditions 1.38671875
, 0.09576416015625
▁emot 5.3984375
ional 0.07806396484375
▁states 1.3115234375
, 0.11572265625
▁and 0.461669921875
▁so 3.2421875
▁on 0.30712890625
. 0.096923828125
<0x0A> 0.7705078125
The 1.15234375
▁analysis 4.59765625
▁of 0.54345703125
▁any 8.75
▁human 5.984375
▁reaction 4.91796875
▁has 4.62109375
▁a 1.7783203125
▁high 4.46484375
▁potential 3.5
▁of 1.642578125
▁subject 6.23046875
iveness 3.75390625
▁and 1.322265625
▁bias 2.478515625
, 1.8173828125
▁especially 2.62109375
▁regarding 4.375
▁people 4.60546875
▁in 3.91796875
▁severe 4.26171875
▁pain 0.77197265625
▁and 2.435546875
▁un 5.359375
stable 1.806640625
▁emot 0.7919921875
ional 0.1995849609375
▁condition 2.8203125
. 0.08258056640625
▁Perhaps 8.859375
▁some 4.92578125
▁patients 2.3125
▁tend 5.53125
▁to 0.0247039794921875
▁ex 2.560546875
agger 0.0029087066650390625
ate 0.007366180419921875
▁their 0.7158203125
▁de 4.88671875
press 0.99951171875
ive 1.2705078125
▁state 3.1953125
▁or 1.8759765625
▁vice 7.34375
▁vers 0.0222015380859375
a 0.00791168212890625
, 1.0634765625
▁de 7.28125
- 4.4453125
emph 0.91943359375
as 0.01517486572265625
ize 0.127685546875
▁serious 6.61328125
▁difficulties 5.99609375
. 0.87255859375
▁Because 6.05859375
▁the 2.228515625
▁survey 6.05859375
▁responses 6.625
▁were 1.63671875
▁thoroughly 8.203125
▁anonymous 5.01171875
, 0.47119140625
▁the 1.443359375
▁research 1.525390625
ers 0.270263671875
▁were 1.4619140625
▁unable 2.3671875
▁to 0.00543212890625
▁carefully 8.796875
▁analyze 1.53125
▁each 3.94140625
▁patient 2.41015625
’ 26.328125
s 0.701171875
▁reaction 3.6015625
▁and 2.453125
▁compare 3.431640625
▁it 0.83056640625
▁to 1.2265625
▁the 0.76318359375
▁actual 5.57421875
▁states 7.26171875
▁of 0.685546875
▁condition 7.21875
. 0.368896484375
▁More 7.0234375
▁accurate 3.869140625
▁answers 4.74609375
▁could 2.4921875
▁be 0.8603515625
▁obtained 0.927734375
▁by 1.359375
▁professional 7.578125
▁psych 2.181640625
olog 0.333740234375
ists 0.005924224853515625
▁via 8.0546875
▁personal 3.88671875
▁communication 4.58203125
▁and 1.8759765625
▁behavior 7.1875
al 0.339599609375
▁analysis 2.23046875
. 0.240478515625
▁However 2.7109375
, 0.003757476806640625
▁this 1.900390625
▁method 2.8671875
▁of 2.24609375
▁research 2.1953125
▁is 0.92626953125
▁way 8.046875
▁more 1.6689453125
▁resource 6.578125
- 0.404296875
int 0.56787109375
ensive 0.01119232177734375
▁and 0.63818359375
▁energy 8.6171875
- 0.1278076171875
consum 0.317138671875
ing 0.00391387939453125
. 0.6044921875
<0x0A> 0.5966796875
Part 5.6640625
icip 0.097900390625
ants 0.1541748046875
▁were 1.0009765625
▁rec 1.6279296875
ru 0.0018367767333984375
ited 0.0003707408905029297
▁for 1.15234375
▁six 1.2880859375
▁months 0.0224761962890625
▁at 0.472900390625
▁two 0.10748291015625
▁major 0.2939453125
▁pain 0.04388427734375
▁relief 0.0302276611328125
▁cent 0.0279541015625
ers 0.01047515869140625
▁in 0.06536865234375
▁Israel 0.034149169921875
. 0.1534423828125
▁All 3.482421875
▁patients 1.556640625
▁experienced 5.625
▁chron 1.814453125
ic 0.003292083740234375
▁pain 0.1256103515625
▁for 3.259765625
▁at 0.68701171875
▁least 0.0021686553955078125
▁ 0.9912109375
3 1.4765625
▁months 0.224853515625
. 0.99658203125
▁The 1.44921875
▁study 1.9345703125
▁included 2.126953125
▁ 1.0986328125
8 2.8515625
9 2.78125
0 3.654296875
▁particip 7.5703125
an 5.30859375
T 0.99365234375
s 0.069580078125
, 1.330078125
▁of 1.68359375
▁which 0.478515625
▁ 0.1365966796875
4 1.7470703125
7 2.421875
4 2.728515625
▁( 1.9794921875
5 0.100830078125
9 11.1640625
%) 0.9677734375
▁were 0.4462890625
▁treated 4.92578125
▁sole 6.90625
ly 0.0007243156433105469
▁with 0.568359375
▁op 0.7470703125
io 0.3388671875
ids 0.1990966796875
, 1.1787109375
▁ 0.6201171875
3 1.119140625
2 2.12890625
9 2.4609375
▁( 0.051666259765625
4 1.2001953125
1 1.251953125
%) 0.1407470703125
▁were 1.2646484375
▁treated 0.435791015625
▁with 0.191650390625
▁MM 0.97412109375
, 0.235595703125
▁and 0.14697265625
▁ 0.12469482421875
7 2.9296875
7 2.396484375
▁( 0.2159423828125
8 3.9140625
. 1.1767578125
6 2.802734375
%) 0.056396484375
▁acquired 9.9765625
▁both 1.0927734375
▁( 6.88671875
Fe 10.0390625
ing 4.25390625
old 0.02392578125
▁et 1.330078125
▁al 0.034210205078125
., 0.349365234375
▁ 0.015167236328125
2 0.199462890625
0 0.0011997222900390625
1 0.4619140625
7 2.177734375
). 0.1536865234375
▁The 1.314453125
▁remaining 7.109375
▁ten 8.171875
▁participants 1.2880859375
▁who 5.5
▁did 1.4228515625
▁not 0.0094451904296875
▁receive 1.876953125
▁ph 3.103515625
arma 0.06292724609375
ce 0.004055023193359375
ut 0.00194549560546875
ical 0.0034198760986328125
▁op 0.86376953125
io 0.090576171875
ids 0.0240631103515625
▁and 1.681640625
▁medical 1.89453125
▁mar 0.04791259765625
iju 0.01214599609375
ana 0.0009031295776367188
▁were 1.353515625
▁with 5.9375
dra 0.177001953125
wn 0.0018205642700195312
▁from 0.271728515625
▁the 0.106201171875
▁analysis 4.640625
▁in 4.83203125
▁the 1.216796875
▁research 4.40625
. 0.76171875
▁Therefore 4.953125
, 0.0099029541015625
▁it 3.8125
▁is 0.85791015625
▁n 9.171875
O 2.4140625
t 0.548828125
▁possible 0.78369140625
▁to 0.0318603515625
▁compreh 6.44921875
ens 0.09002685546875
ively 0.041656494140625
▁compare 1.8212890625
▁patients 4.609375
▁taking 4.375
▁medic 3.62890625
ations 0.4267578125
▁with 0.99951171875
▁those 1.1552734375
▁who 1.2158203125
▁do 1.6689453125
▁not 0.016326904296875
. 0.75927734375
<0x0A> 0.5576171875
The 1.1884765625
▁study 1.740234375
▁conducted 4.75
▁a 2.197265625
▁correlation 6.15625
▁type 7.55859375
▁of 0.444091796875
▁research 2.041015625
▁with 2.826171875
▁variable 8.0390625
▁measures 4.48828125
. 1.31640625
▁It 2.142578125
▁evaluated 4.5546875
▁the 0.55908203125
▁inter 6.1875
dep 3.66015625
end 0.0080413818359375
ence 0.013092041015625
▁of 0.537109375
▁various 4.00390625
▁factors 1.66015625
▁that 2.759765625
▁affected 4.09765625
▁the 0.55908203125
▁physical 6.9375
▁and 0.82568359375
▁emot 0.486572265625
ional 0.0010128021240234375
▁condition 1.1572265625
▁of 0.10833740234375
▁patients 0.62451171875
▁experien 4.3984375
cing 0.0009851455688476562
▁chron 0.52099609375
ic 0.0009889602661132812
▁pain 0.039581298828125
. 0.2401123046875
▁For 3.958984375
▁example 1.1865234375
, 0.02001953125
▁the 1.208984375
▁su 10.8359375
R 3.396484375
vey 0.60693359375
▁showed 3.923828125
▁that 0.495849609375
▁the 1.775390625
▁ratio 7.171875
▁of 0.1307373046875
▁female 4.625
▁patients 0.95166015625
▁was 1.9521484375
▁remark 9.8359375
ably 0.00621795654296875
▁higher 0.476318359375
▁in 2.63671875
▁the 0.93017578125
▁op 4.35546875
i 3.482421875
ates 0.253662109375
▁group 0.285400390625
▁compared 2.798828125
▁to 0.1356201171875
▁the 0.455810546875
▁MM 0.489501953125
▁group 0.26025390625
. 0.515625
▁In 3.021484375
▁turn 4.23046875
, 0.00513458251953125
▁people 6.31640625
▁on 5.39453125
▁op 1.2197265625
i 0.5791015625
ates 0.00653839111328125
▁were 1.099609375
▁more 1.0234375
▁likely 0.391357421875
▁to 0.070556640625
▁report 3.1796875
▁major 6.0234375
▁de 0.43994140625
press 0.76611328125
ive 0.044036865234375
▁dis 0.50634765625
orders 1.630859375
. 1.810546875
<0x0A> 2.83203125
The 1.173828125
▁question 5.30078125
na 1.166015625
ires 0.0017919540405273438
▁u 11.78125
S 1.7353515625
ed 0.13916015625
▁different 9.4140625
▁variable 8.515625
▁measures 0.712890625
▁to 1.2001953125
▁collect 2.185546875
▁information 2.2109375
. 1.96484375
▁For 2.048828125
▁example 0.20654296875
, 0.01108551025390625
▁it 3.724609375
▁included 2.439453125
▁compreh 8.765625
ensive 0.023468017578125
▁so 6.94921875
cio 0.1116943359375
- 0.44287109375
dem 0.10504150390625
ographic 0.045379638671875
▁data 1.1220703125
: 4.74609375
▁gender 1.6728515625
, 0.0997314453125
▁age 0.2139892578125
, 0.0831298828125
▁country 4.35546875
, 1.470703125
▁type 4.25390625
▁of 0.059967041015625
▁residence 3.876953125
▁( 3.353515625
urban 2.1953125
/ 2.921875
r 0.0655517578125
ural 0.0113983154296875
), 0.232177734375
▁years 5.94921875
▁of 0.1650390625
▁education 0.75390625
, 0.159423828125
▁and 1.8330078125
▁employ 3.73828125
ment 0.00954437255859375
▁status 0.43603515625
. 0.185546875
▁Pat 3.921875
ients 0.10101318359375
▁were 1.185546875
▁also 0.8525390625
▁asked 0.58837890625
▁about 1.19140625
▁their 0.57568359375
▁medical 2.66796875
▁history 0.412109375
▁over 8.71875
▁the 0.162353515625
▁years 4.0546875
▁and 1.8017578125
▁the 1.8203125
▁current 3.275390625
▁presence 5.8984375
▁of 0.057464599609375
▁any 2.6875
▁severe 4.6328125
▁dise 1.716796875
ases 0.001613616943359375
▁such 4.15234375
▁as 0.006298065185546875
▁heart 2.3984375
▁failure 1.974609375
, 0.19091796875
▁di 1.94140625
ab 0.003406524658203125
etes 0.006504058837890625
, 0.1395263671875
▁ar 3.78515625
th 0.11236572265625
rit 0.042022705078125
is 0.0164794921875
, 0.045166015625
▁and 1.625
▁so 0.76513671875
▁on 0.032318115234375
. 0.0458984375
▁The 1.7978515625
▁third 7.26953125
▁measure 4.265625
▁of 1.9609375
▁the 0.96240234375
▁question 2.287109375
naire 0.202392578125
▁was 1.0009765625
▁indicated 9.75
▁by 0.59228515625
▁info 12.1796875
R 3.48828125
m 0.290771484375
ation 0.1864013671875
▁on 1.5380859375
▁any 5.26171875
▁twelve 13.8046875
- 1.34765625
month 0.5322265625
▁and 5.80078125
▁lifetime 3.62890625
▁drug 4.46484375
▁an 10.7265625
D 0.041015625
▁alco 0.1654052734375
hol 0.002407073974609375
▁consumption 2.6015625
. 0.4873046875
▁In 3.65234375
▁addition 0.8701171875
, 0.1251220703125
▁the 1.1259765625
▁record 7.609375
▁included 1.7236328125
▁a 2.4296875
▁pain 6.48828125
▁measurement 4.46484375
▁scale 1.07421875
▁from 3.6328125
▁ 0.417236328125
0 0.4384765625
▁to 0.47265625
▁ 0.01091766357421875
1 0.09942626953125
0 0.0765380859375
▁to 4.609375
▁evaluate 1.5546875
▁dis 6.14453125
com 0.168701171875
fort 0.01410675048828125
▁Fe 12.03125
el 3.77734375
ings 0.033111572265625
▁during 3.21875
▁the 0.9111328125
▁last 1.8115234375
▁month 1.6396484375
. 0.4931640625
<0x0A> 0.91162109375
Am 6.82421875
ong 0.03338623046875
▁all 2.1171875
▁participants 2.005859375
▁in 3.634765625
▁the 0.1700439453125
▁study 0.37841796875
, 0.06365966796875
▁ 0.67236328125
4 1.806640625
2 2.75390625
. 1.7236328125
2 2.296875
% 0.152099609375
▁suffered 5.03515625
▁from 0.1492919921875
▁de 1.9765625
pression 0.412353515625
, 1.087890625
▁and 1.74609375
▁ 0.154052734375
3 1.73046875
7 2.23046875
% 2.693359375
▁experienced 2.306640625
▁excess 7.87890625
ive 0.0948486328125
▁anx 0.26611328125
iety 0.0062255859375
. 0.330810546875
▁The 1.380859375
▁pl 11.1328125
ur 1.0595703125
ality 0.002658843994140625
▁of 0.1973876953125
▁de 3.755859375
press 0.71484375
ive 0.184814453125
▁dis 1.8837890625
orders 0.06884765625
▁among 3.759765625
▁patients 1.1826171875
▁in 3.890625
▁the 0.329345703125
▁op 1.326171875
i 0.966796875
ates 0.00942230224609375
, 7.12890625
▁medical 2.63671875
▁mar 0.023651123046875
iju 0.0184478759765625
ana 0.0004944801330566406
, 0.11871337890625
▁and 0.06744384765625
▁mixed 5.7578125
▁OP 8.59375
MM 7.65234375
▁groups 0.59033203125
▁number 8.25
ed 0.0133209228515625
▁ 0.123779296875
5 2.166015625
7 2.486328125
. 0.2095947265625
1 2.376953125
%, 0.243408203125
▁ 0.00556182861328125
2 2.9609375
2 2.435546875
. 0.10009765625
3 2.248046875
%, 0.11798095703125
▁and 0.03399658203125
▁ 0.004360198974609375
5 3.201171875
1 2.59375
. 0.17138671875
4 2.15234375
%, 0.379638671875
▁respectively 0.019805908203125
. 0.25732421875
▁The 1.421875
▁pl 4.4453125
ur 0.025970458984375
ality 0.00010180473327636719
▁of 0.039642333984375
▁anx 0.90380859375
iety 0.023040771484375
▁contained 11.0859375
▁ 0.619140625
4 1.59375
8 2.373046875
. 0.06365966796875
4 2.310546875
% 0.5419921875
▁among 1.48828125
▁OP 6.79296875
▁patients 9.3125
, 0.291015625
▁ 0.1063232421875
2 1.5302734375
1 2.42578125
. 0.12841796875
5 2.44140625
% 0.01204681396484375
▁among 0.40673828125
▁MM 0.3466796875
▁patients 0.25439453125
, 0.01222991943359375
▁and 0.0152435302734375
▁ 0.040802001953125
3 1.263671875
8 2.638671875
. 0.14794921875
7 2.2734375
% 0.01470184326171875
▁among 0.2003173828125
▁OP 4.55078125
MM 0.350341796875
▁participants 3.3984375
. 0.191162109375
▁Pat 5.5546875
ients 0.0233612060546875
▁who 2.4375
▁took 2.876953125
▁strong 8.2578125
▁op 1.0322265625
i 1.5693359375
ates 0.005268096923828125
▁were 1.796875
▁t 8.4296875
ended 1.2705078125
▁to 0.0167999267578125
▁place 10.40625
▁their 3.705078125
▁pain 2.556640625
▁on 3.068359375
▁a 0.8271484375
▁scale 2.564453125
▁of 0.63037109375
▁ 0.29052734375
9 2.822265625
▁to 1.3095703125
▁ 0.0177764892578125
1 0.023468017578125
0 0.0833740234375
▁( 2.55078125
Fe 1.6962890625
ing 0.046295166015625
old 0.0036182403564453125
▁et 0.0215301513671875
▁al 0.00441741943359375
., 0.007663726806640625
▁ 0.0031528472900390625
2 0.0007863044738769531
0 0.00016200542449951172
1 0.0029239654541015625
7 0.0177001953125
). 0.052520751953125
▁They 4.53125
▁were 1.32421875
▁also 1.4169921875
▁an 8.4296875
gu 4.8046875
ished 0.07073974609375
▁em 8.4140625
otion 0.0799560546875
ally 0.01161956787109375
▁and 1.224609375
▁react 7.15234375
ed 0.0509033203125
▁rad 9.671875
ically 0.07293701171875
▁neg 5.078125
atively 0.0029811859130859375
▁to 0.34375
▁almost 5.12109375
▁all 1.24609375
▁survey 8.2890625
▁questions 0.7548828125
. 0.2802734375
▁Pat 4.2578125
ients 0.00897216796875
▁who 1.16015625
▁took 1.4609375
▁only 5.51953125
▁MM 0.873046875
▁or 3.3828125
▁mixed 3.263671875
▁medic 2.80859375
ations 0.361328125
▁course 12.6171875
▁had 2.421875
▁a 1.212890625
▁significantly 2.666015625
▁more 3.9375
▁stable 3.51953125
▁emot 1.26953125
ional 0.01202392578125
▁state 0.71630859375
▁and 1.4140625
▁cop 5.921875
ed 1.064453125
▁with 0.7568359375
▁pain 1.544921875
▁more 1.603515625
▁manage 6.84765625
able 2.388671875
. 0.499267578125
<0x0A> 0.65869140625
One 5.23828125
▁of 0.63427734375
▁the 0.020904541015625
▁major 2.595703125
▁limitations 2.69921875
▁is 4.09765625
▁the 0.52734375
▁ins 4.60546875
u 0.0232391357421875
fficient 0.11126708984375
ly 4.8984375
▁high 3.04296875
▁response 2.94140625
▁rate 0.1253662109375
, 2.69921875
▁ 4.51953125
5 1.97265625
7 2.001953125
% 2.046875
▁instead 7.33984375
▁of 0.0087432861328125
▁ 0.74462890625
7 1.5068359375
0 1.54296875
% 1.1025390625
▁( 1.7109375
Fe 0.280029296875
ing 0.0100860595703125
old 0.00279998779296875
▁et 0.00615692138671875
▁al 0.00270843505859375
., 0.005908966064453125
▁ 0.0021305084228515625
2 0.0005564689636230469
0 6.306171417236328e-05
1 0.0013904571533203125
7 0.0079803466796875
). 0.040557861328125
▁It 2.697265625
▁can 3.244140625
▁be 0.4287109375
▁fairly 8.46875
▁expla 9.5546875
In 2.75
ed 0.1961669921875
▁by 0.403076171875
▁the 0.320068359375
▁weak 8.0625
▁focus 7.25
▁of 0.46533203125
▁respond 6.09765625
ents 0.14111328125
▁who 3.46484375
▁have 4.2890625
▁overcome 8.109375
▁severe 2.357421875
▁pain 0.607421875
▁sens 8.53125
ations 1.0595703125
▁and 1.265625
▁de 4.109375
press 1.375
ive 0.2744140625
▁episodes 4.27734375
. 0.607421875
▁It 3.271484375
▁is 0.77001953125
▁not 2.6328125
▁clear 4.4375
▁how 1.634765625
▁to 3.69140625
▁use 5.3359375
▁these 3.001953125
▁statistics 3.57421875
, 2.609375
▁as 1.2021484375
▁they 1.34765625
▁still 6.25390625
▁may 4.734375
▁be 1.4296875
▁relevant 5.82421875
▁for 1.431640625
▁the 1.8662109375
▁overall 4.515625
▁analysis 3.09375
. 1.033203125
